REG - Cambridge Cognition - Posting of Annual Report & Notice of AGM

Cambridge Cognition HoldingsAnnouncement

Today 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260424:nRSX8942Ba&default-theme=true

RNS Number : 8942B  Cambridge Cognition Holdings PLC  24 April 2026

24 April 2026

Cambridge Cognition Holdings plc

("Cambridge Cognition" or the "Company")

 

 

Posting of Annual Report & Notice of AGM

 

 

Cambridge Cognition Holdings plc (AIM: COG), the neuroscience technology
company whose digital cognitive assessments drive scientific discovery,
accelerate drug development and improve patient care, confirms that the Annual
Report and Accounts for the year ended 31 December 2025 ("2025 Annual Report")
and the Notice of the Annual General Meeting ("AGM") have been published on
the Company's website. Hard copies have been posted to those shareholders who
requested them.

 

The AGM is to be held at 9 am BST on 21 May 2026 at the registered office of
the Company, Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25
9TU.

 

A copy of the 2025 Annual Report and other documents are available on the
Company's website: https://cambridgecognition.com/reports-and-accounts/
(https://cambridgecognition.com/reports-and-accounts/)

 

 

 

 

Enquiries:

 

 Cambridge Cognition Holdings plc                            Tel: 01223 810700

 Rob Baker, Chief Executive Officer                          press@camcog.com (mailto:press@camcog.com)

 Ronald Openshaw, Chief Financial Officer

 Cavendish Capital Markets Limited (NOMAD and Joint Broker)  Tel: 020 7220 0500

 Geoff Nash / Elysia Bough / Joe Smith                       Corporate Finance

 Harriet Ward                                                Corporate Broking

 Nigel Birks                                                 LS Specialist Sales

 Singer Capital Markets Limited (Joint Broker)               Tel: 020 7496 3000

 Amber Higgs / James Serjeant / Daniel Ingram

 

Notes to Editors

 

About Cambridge Cognition

 

Cambridge Cognition is a neuroscience technology company whose digital
cognitive assessments drive scientific discovery, accelerate drug development
and improve patient care.

 

Built on rich, curated data and deep technical expertise we are building a
strong global brand with scalable technology that will support the rising
world demand for diagnosing and treating brain health.  The Company creates
shareholder value through organic sales growth, strategic partnerships, joint
ventures, and spinouts.  The Company has identified four market sectors:

 

·      Clinical Studies for new pharmaceuticals;

·      Academic Research for scientists to understand CNS disorders;

·      Healthcare to provide physicians with cognitive assessments to
allow them to diagnose and treat patients; and,

·      Consumer Health & Wellness to provide individuals access to
accurate, reliable, and meaningful data to assess their cognitive health.

 

For further information, visit: www.cambridgecognition.com
(http://www.cambridgecognition.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSEALLLAFLKEFA



            Copyright 2019 Regulatory News Service, all rights reserved